Pharma Industry News 26 November 2025

Eli Lilly (LLY) Stock on December 8, 2025: China Insurance Win, Trillion‑Dollar Status and What Comes Next for Investors

Updated: December 8, 2025 – For informational purposes only, not investment advice. Key takeaways 1. Where Eli Lilly (LLY) stands on December 8, 2025 As U.S. markets trade on Monday, Eli Lilly and Company (NYSE: LLY) is changing hands near

8 December 2025

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

Data and news current as of 7 December 2025. NVAX stock price now: where Novavax stands in December 2025 Novavax, Inc. (NASDAQ: NVAX) closed on Friday, 5 December 2025 at $6.91 per share, giving the vaccine maker a market value

7 December 2025

Biotech · Investing · Market Analysis · NASDAQ:NVAX · Pharma Industry · Stocks

Sun Pharma Advanced Research (SPARC) Stock Soars After US Court Ruling on Sezaby PRV – What the 30% Two‑Day Rally on 3 December 2025 Really Means

SPARC stock on 3 December 2025: Still volatile after a 2‑day surge Sun Pharma Advanced Research Company Ltd (SPARC) has exploded back onto traders’ screens this week. On 2 December 2025, the stock hit the 20% upper circuit at around

3 December 2025

Court Rulings · Financial News · Investment Analysis · Pharma Industry · Stock Market

AbbVie (ABBV) Stock on December 2, 2025: Dividend Hike, Cancer Pipeline Momentum and 2026 Outlook

AbbVie Inc. (NYSE: ABBV) heads into the final month of 2025 as one of the most closely watched large‑cap healthcare stocks, with fresh dividend news, new oncology and migraine data, and an upbeat earnings outlook all hitting the tape just

2 December 2025

Dividends · Investment Analysis · Market Outlook · NYSE:ABBV · Pharma Industry · Stocks

Pfizer (PFE) Stock on December 2, 2025: Price, Metsera Deal, New FDA Risks and 2026 Outlook

As of late trading on Tuesday, December 2, 2025, Pfizer (NYSE: PFE) shares change hands around $25.10, down roughly 0.7% on the day and sitting in the middle of their 52‑week range of $20.92–$27.69. Yahoo Finance+1 The stock carries a dividend yield

2 December 2025

FDA Updates · Investment Outlook · NYSE:PFE · Pfizer News · Pharma Industry · Stock Analysis

Johnson & Johnson (JNJ) Stock News & Forecast: EU Drug Approval, $3B Cancer Deal and Dividend Strength – December 1, 2025

As of December 1, 2025. This article is for information only and is not investment advice. JNJ stock today: riding near record highs after a huge 2025 rally Johnson & Johnson (NYSE: JNJ) stock is trading close to its 52‑week

1 December 2025

Cancer Research · Dividend Stocks · Investment News · NYSE:JNJ · Pharma Industry · Stock Market

Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Updated November 30, 2025 Pfizer stock is in the middle of a big reset. The COVID windfall is fading, but a massive obesity-drug acquisition, a landmark bladder‑cancer approval and a high dividend yield are reshaping the story investors see in

30 November 2025

Company News · Investment Analysis · Mergers & Acquisitions · Pharma Industry · Stock Market

Merck Stock (MRK) Outlook Before the December 1, 2025 Market Open: Rally, Ratings and Pipeline Catalysts

Merck & Co., Inc. (NYSE: MRK) heads into the Monday, December 1, 2025 market open riding one of the strongest monthly rallies in the S&P 500, powered by upbeat earnings, dividend growth and a string of bullish analyst calls focused

30 November 2025

Earnings Preview · Investment Strategies · Market Outlook · NYSE:MRK · Pharma Industry · Stock Analysis

AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Inc. (NYSE: ABBV) ended Friday’s session almost unchanged, closing around $227.70 per share, up a negligible 0.02%, after earlier trading slightly in the red. StockAnalysis+2StockAnalysis+2 Even with today’s flat finish, the pharma giant remains one of 2025’s standout healthcare

28 November 2025

Dividends · Investing · Market News · Pharma Industry · Stocks

Novo Nordisk Stock Today, 28 November 2025: Goldman Sachs Trims Target as Obesity Pipeline Fights Back

Novo Nordisk (NYSE: NVO) shares are trying to stabilise after a bruising November as fresh obesity‑drug data, a higher‑dose Wegovy filing and new analyst calls collide with lingering worries about growth and competition. 1. How Novo Nordisk stock is trading

28 November 2025

Analyst Ratings · Investment News · NYSE:NVO · Obesity Treatments · Pharma Industry · Stock Market

Eli Lilly (LLY) Stock Outlook Before Market Open on November 28, 2025: Trillion‑Dollar Pharma in Focus

As U.S. markets prepare for a shortened Black Friday session on Friday, November 28, 2025, Eli Lilly and Company (NYSE: LLY) will open trading as one of the most closely watched stocks on Wall Street. The drugmaker has just joined

27 November 2025

Company Outlook · Financial News · Investment Analysis · NYSE:LLY · Pharma Industry · Stock Market

Eli Lilly (LLY) Stock on November 26, 2025: Trillion‑Dollar Milestone, Pricing Shake‑Up and Stock‑Split Buzz

Eli Lilly and Company (NYSE: LLY) is having another headline‑heavy session on Wednesday, November 26, 2025, as investors digest its new status as the first trillion‑dollar healthcare company, fresh moves on obesity‑drug pricing, and growing chatter about a potential stock

26 November 2025

Company Analysis · Financial Trends · Investment News · NYSE:LLY · Pharma Industry · Stock Market

Pharma Industry News 26 November 2025 - 8 December 2025